首页> 美国卫生研究院文献>Translational Lung Cancer Research >Cons: should a medically inoperable patient with a T2N0M0 non-small cell lung cancer central in the lung hilus be treated using stereotactic body radiotherapy?

【2h】

Cons: should a medically inoperable patient with a T2N0M0 non-small cell lung cancer central in the lung hilus be treated using stereotactic body radiotherapy?

机译：缺点：是否应使用立体定向放射疗法治疗在肺门中央有T2N0M0非小细胞肺癌的医学上无法手术的患者？

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

期刊名称 Translational Lung Cancer Research
作者
Ursula Nestle; José Belderbos;
展开▼
作者单位

展开▼
年(卷),期 2015(4),5
年度 2015
页码 623–626
总页数 4
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. A randomized Phase III trial of comparing two dose-fractionations stereotactic body radiotherapy (SBRT) for medically inoperable Stage IA non-small cell lung cancer or small lung lesions clinically diagnosed as primary lung cancer: Japan Clinical Oncology Group Study JCOG1408 (J-SBRT trial) [J] . Kimura Tomoki, Nagata Yasushi, Eba Junko, Japanese journal of clinical oncology. . 2017,第3期

机译：用于比较两种剂量分数立体定向体放射疗法（SBRT）的随机期III试验，用于医学上不可操作的阶段IA非小细胞肺癌或小肺病变临床诊断为原发性肺癌：日本临床肿瘤学群体学习JCOG1408（J-SBRT试验的）
2. The role of stereotactic body radiotherapy in the management of non-small cell lung cancer: an emerging standard for the medically inoperable patient? [J] . Videtic GM, Stephans KL Current oncology reports. . 2010,第4期

机译：立体定向放射疗法在非小细胞肺癌治疗中的作用：对于无法手术的患者而言，这是一个新兴标准？
3. Stereotactic body radiotherapy for medically inoperable patients with stage I non-small cell lung cancer - a first report of toxicity related to COPD/CVD in a non-randomized prospective phase II study. [J] . Baumann P, Nyman J, Hoyer M, Radiotherapy and oncology: Journal of the European Society for Therapeutic Radiology and Oncology . 2008,第3期

机译：立体定向放射疗法用于不可手术的I期非小细胞肺癌患者-一项非随机前瞻性II期研究首次报道了与COPD / CVD相关的毒性。
4. CHANGES IN LUNG PERFUSION DISTRIBUTION DUE TO RADIATION IN LUNG CANCER PATIENTS TREATED WITH 3D CONFORMAL RADIATION THERAPY AND STEREOTACTIC BODY RADIATION THERAPY [C] . Lingshu Yin, Mitchell Liu, Jonn Wu, World Congress on Medical Physics and Biomedical Engineering . 2013

机译：3D保形放射治疗和定性体放射治疗对肺癌患者放射致肺灌注分布的变化
5. An investigation of the determinates of survival in patients with inoperable non-small cell lung cancer: The role of the systemic inflammatory response [D] . Forrest, Lynn M. 2004

机译：不可手术的非小细胞肺癌患者生存决定因素的研究：全身炎症反应的作用
6. Pros: should a medically inoperable patient with a T2N0M0 non-small cell lung cancer central in the lung hilus be treated using stereotactic body radiotherapy? [O] . Katrina Woodford, Sashendra Senthi 2015

机译：优点：是否应该使用立体定向放射疗法治疗在肺门中央有T2N0M0非小细胞肺癌的医学上无法手术的患者？
7. PD5-2-6: Hypofractionated stereotactic body radiotherapy in patients with peripherally or centrally located medically inoperable stage I or isolated recurrent non-small cell lung cancer [O] . Chang Joe Y., Balter Peter, Liao Zhongxing, 2007

机译：PD5-2-6：对处于外围或中心位置的医学上不能手术的I期患者或孤立的复发性非小细胞肺癌患者的超分割立体定向放射疗法
8. Phase 1 Trial of an Immune Checkpoint Inhibitor plus Stereotactic Ablative Radiotherapy in Patients with Inoperable Stage I Non-Small Cell Lung Cancer. [R] . Kelly, K., Monjazeb, A., Daly, M., 2017

机译：免疫检查点抑制剂加立体定向消融放疗治疗不能手术的I期非小细胞肺癌的1期试验。

Cons: should a medically inoperable patient with a T2N0M0 non-small cell lung cancer central in the lung hilus be treated using stereotactic body radiotherapy?

著录项

相似文献

相关主题

期刊订阅